Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryo-EM
Sci Adv. 2025 Aug 15;11(33):eadv8257. doi: 10.1126/sciadv.adv8257. Epub 2025 Aug 15.
PMID:
From first infection to reinfection: Comparing Nucleocapsid antibody kinetics in vaccinated and unvaccinated adults
Vaccine. 2025 Aug 30;62:127593. doi: 10.1016/j.vaccine.2025.127593. Epub 2025 Aug 13.
PMID:
Clonotype-enriched somatic hypermutations drive affinity maturation of a public human antibody targeting an occluded sarbecovirus epitope
Cell Rep. 2025 Aug 26;44(8):116122. doi: 10.1016/j.celrep.2025.116122. Epub 2025 Aug 12.
PMID:
Molecular organization of the New World arenavirus spike glycoprotein complex
Nat Microbiol. 2025 Sep;10(9):2207-2220. doi: 10.1038/s41564-025-02085-6. Epub 2025 Aug 8.
PMID:
A single residue change only differing by an atomic group can drive imprinting to influenza
Res Sq [Preprint]. 2025 Jul 7:rs.3.rs-6914018. doi: 10.21203/rs.3.rs-6914018/v1.
PMID:
Integrative mapping of preexisting influenza immune landscapes predicts vaccine response
J Clin Invest. 2025 Jul 15;135(18):e189300. doi: 10.1172/JCI189300. eCollection 2025 Sep 16.
PMID:
Characterization of the glycoproteins of novel fish influenza B-like viruses
bioRxiv [Preprint]. 2025 May 8:2025.05.08.652883. doi: 10.1101/2025.05.08.652883.
PMID:
Evaluating Modes of Influenza Transmission (EMIT-2): Insights from a Controlled Human Influenza Virus Infection Transmission Trial (CHIVITT)
medRxiv [Preprint]. 2025 Sep 29:2025.04.28.25326458. doi: 10.1101/2025.04.28.25326458.
PMID:
Purification and characterization of recombinant neuraminidase as a potentially broadly protective influenza virus vaccine candidate
Vaccine. 2025 Aug 30;62:127471. doi: 10.1016/j.vaccine.2025.127471. Epub 2025 Jul 11.
PMID:
Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants
NPJ Vaccines. 2025 Jul 10;10(1):149. doi: 10.1038/s41541-025-01209-7.
PMID: